Inspire Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results

DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today financial results for the fourth quarter and year ended December 31, 2007, reporting a net loss of $18.1 million for the fourth quarter and a net loss of $63.7 million for the full year. In the fourth quarter, the Company recorded a non-cash dividend of $8.3 million related to the exchange of all outstanding Series A Exchangeable Preferred Stock to common stock, which increased net loss per common share by ($0.16) in the fourth quarter and ($0.19) for the year ended December 31, 2007. Accordingly, the Company reported net loss per common share of ($0.51) for the fourth quarter and ($1.61) for the full year.

Back to news